| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.56B | 125.50B | 120.66B | 120.98B | 107.63B | 101.90B |
| Gross Profit | 12.36B | 12.63B | 10.21B | 9.58B | 7.37B | 8.40B |
| EBITDA | 7.79B | 5.37B | 5.97B | 4.66B | 3.68B | 3.92B |
| Net Income | 4.73B | 4.25B | 3.50B | 2.74B | 2.25B | 1.81B |
Balance Sheet | ||||||
| Total Assets | 199.02B | 217.46B | 206.76B | 203.61B | 155.75B | 155.10B |
| Cash, Cash Equivalents and Short-Term Investments | 14.53B | 25.40B | 12.54B | 17.49B | 17.58B | 33.70B |
| Total Debt | 33.35B | 33.31B | 36.90B | 33.49B | 13.60B | 13.71B |
| Total Liabilities | 99.66B | 102.21B | 109.89B | 110.68B | 76.52B | 80.79B |
| Stockholders Equity | 99.36B | 115.24B | 96.87B | 92.93B | 79.22B | 74.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 17.35B | -8.05B | -22.97B | -16.25B | -14.24B |
| Operating Cash Flow | 0.00 | 18.75B | -7.73B | -22.39B | -2.91B | -13.72B |
| Investing Cash Flow | 0.00 | -1.34B | -26.00M | 2.67B | -12.98B | -1.41B |
| Financing Cash Flow | 0.00 | -4.48B | 2.66B | 19.30B | -696.00M | -394.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥51.46B | 11.23 | ― | 4.90% | -4.13% | 19.71% | |
70 Outperform | ¥46.41B | 11.14 | ― | 3.78% | 24.67% | 72.89% | |
67 Neutral | ¥63.83B | 10.30 | ― | 2.56% | 2.50% | 21.22% | |
66 Neutral | ¥66.03B | 14.37 | ― | 3.84% | -2.49% | 23.25% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥61.81B | 14.53 | ― | 1.57% | 4.01% | 21.41% | |
54 Neutral | ¥43.36B | 9.90 | ― | 2.84% | 21.15% | 18.25% |